National Health Investors (NYSE:NHI) Upgraded by Zacks Investment Research to “Buy”

Zacks Investment Research upgraded shares of National Health Investors (NYSE:NHI) from a hold rating to a buy rating in a research note published on Wednesday, Zacks.com reports. The firm currently has $89.00 price objective on the real estate investment trust’s stock.

According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “

NHI stock traded up $0.17 during trading on Wednesday, reaching $80.01. 194,979 shares of the company were exchanged, compared to its average volume of 168,994. The business’s 50-day moving average is $79.33. The company has a market capitalization of $3.46 billion, a P/E ratio of 14.60, a price-to-earnings-growth ratio of 3.61 and a beta of 0.37. National Health Investors has a twelve month low of $70.54 and a twelve month high of $84.57. The company has a debt-to-equity ratio of 0.91, a current ratio of 14.99 and a quick ratio of 14.99.

National Health Investors (NYSE:NHI) last released its quarterly earnings data on Tuesday, May 7th. The real estate investment trust reported $0.83 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.31 by ($0.48). The company had revenue of $76.11 million for the quarter, compared to analyst estimates of $73.21 million. National Health Investors had a return on equity of 10.96% and a net margin of 50.87%. National Health Investors’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.35 earnings per share. As a group, research analysts forecast that National Health Investors will post 5.5 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 9th. Investors of record on Friday, June 28th will be given a dividend of $1.05 per share. This represents a $4.20 dividend on an annualized basis and a yield of 5.25%. The ex-dividend date is Thursday, June 27th. National Health Investors’s dividend payout ratio is 76.64%.

A number of hedge funds have recently added to or reduced their stakes in NHI. Marshall Wace North America L.P. bought a new stake in National Health Investors during the 1st quarter worth approximately $31,000. Farmers National Bank bought a new stake in National Health Investors during the 1st quarter worth approximately $49,000. Quadrant Capital Group LLC grew its holdings in National Health Investors by 306.7% during the 1st quarter. Quadrant Capital Group LLC now owns 793 shares of the real estate investment trust’s stock worth $61,000 after acquiring an additional 598 shares during the last quarter. Brinker Capital Inc. bought a new stake in National Health Investors during the 1st quarter worth approximately $202,000. Finally, Quantamental Technologies LLC grew its holdings in National Health Investors by 200.6% during the 1st quarter. Quantamental Technologies LLC now owns 2,997 shares of the real estate investment trust’s stock worth $235,000 after acquiring an additional 2,000 shares during the last quarter. Institutional investors and hedge funds own 69.98% of the company’s stock.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Recommended Story: Why do companies pay special dividends?

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.